| Fish oil interaction with warfarin MS Buckley, AD Goff, WE Knapp Annals of Pharmacotherapy 38 (1), 50-53, 2004 | 216 | 2004 |
| Direct observation approach for detecting medication errors and adverse drug events in a pediatric intensive care unit MS Buckley, BL Erstad, BJ Kopp, AA Theodorou, G Priestley Pediatric Critical Care Medicine 8 (2), 145-152, 2007 | 159 | 2007 |
| Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit MS Buckley, JM LeBlanc, MJ Cawley Critical care medicine 38, S253-S264, 2010 | 151 | 2010 |
| A critical evaluation of clinical decision support for the detection of drug–drug interactions PL Smithburger, MS Buckley, S Bejian, K Burenheide, SL Kane-Gill Expert opinion on drug safety 10 (6), 871-882, 2011 | 136 | 2011 |
| Impact of a clinical pharmacy admission medication reconciliation program on medication errors in “high-risk” patients MS Buckley, LM Harinstein, KB Clark, PL Smithburger, DJ Eckhardt, ... Annals of Pharmacotherapy 47 (12), 1599-1610, 2013 | 135 | 2013 |
| The cost of opioid-related adverse drug events SL Kane-Gill, EC Rubin, PL Smithburger, MS Buckley, JF Dasta Journal of pain & palliative care pharmacotherapy 28 (3), 282-293, 2014 | 110 | 2014 |
| Clinical practice guideline: safe medication use in the ICU SL Kane-Gill, JF Dasta, MS Buckley, S Devabhakthuni, M Liu, H Cohen, ... Critical care medicine 45 (9), e877-e915, 2017 | 101 | 2017 |
| Stress ulcer prophylaxis JF Barletta, JJ Bruno, MS Buckley, DJ Cook Critical care medicine 44 (7), 1395-1405, 2016 | 91 | 2016 |
| Amiodarone Prophylaxis for Atrial Fibrillation After Cardiac Surgery: Meta‐Analysis of Dose Response and Timing of Initiation MS Buckley, PE Nolan Jr, MK Slack, JE Tisdale, DE Hilleman, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27 (3 …, 2007 | 89 | 2007 |
| Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients MS Buckley, AS Park, CS Anderson, JF Barletta, DS Bikin, RD Gerkin, ... The American journal of medicine 128 (8), 905-913, 2015 | 87 | 2015 |
| An evidence based systematic review of remifentanil associated opioid-induced hyperalgesia RM Rivosecchi, MJ Rice, PL Smithburger, MS Buckley, JC Coons, ... Expert opinion on drug safety 13 (5), 587-603, 2014 | 78 | 2014 |
| A review of inhaled nitric oxide and aerosolized epoprostenol in acute lung injury or acute respiratory distress syndrome AL Dzierba, EE Abel, MS Buckley, I Lat Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (3 …, 2014 | 76 | 2014 |
| Interpatient variability in dexmedetomidine response: a survey of the literature SF Holliday, SL Kane-Gill, PE Empey, MS Buckley, PL Smithburger The Scientific World Journal 2014, 2014 | 59 | 2014 |
| Nebulized milrinone use in a pulmonary hypertensive crisis MS Buckley, JP Feldman Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 27 (12 …, 2007 | 47 | 2007 |
| Evaluation of potential drug–drug interactions in adults in the intensive care unit: a systematic review and meta-analysis MG Fitzmaurice, A Wong, H Akerberg, S Avramovska, PL Smithburger, ... Drug safety 42, 1035-1044, 2019 | 45 | 2019 |
| Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults MS Buckley, JP Feldman Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 30 (7 …, 2010 | 44 | 2010 |
| Drug class combination–associated acute kidney injury RM Rivosecchi, JA Kellum, JF Dasta, MJ Armahizer, S Bolesta, ... Annals of Pharmacotherapy 50 (11), 953-972, 2016 | 42 | 2016 |
| A multicenter evaluation of off-label medication use and associated adverse drug reactions in adult medical intensive care units PL Smithburger, MS Buckley, MA Culver, S Sokol, I Lat, SM Handler, ... Critical care medicine 43 (8), 1612, 2015 | 40 | 2015 |
| Comparison of acute kidney injury risk associated with vancomycin and concomitant piperacillin/tazobactam or cefepime in the intensive care unit MS Buckley, NC Hartsock, AJ Berry, DS Bikin, EC Richards, ... Journal of critical care 48, 32-38, 2018 | 35 | 2018 |
| Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacy MS Buckley, RL Staib, LM Wicks, JP Feldman Drug, healthcare and patient safety, 151-161, 2010 | 35 | 2010 |
